Positive Outcomes Influence the Rate and Time to Publication, but Not the Impact Factor of Publications of Clinical Trial Results
TLDR
Clinical trials with positive outcomes have significantly higher rates and shorter times to publication than those with negative results, however, no differences have been found in terms of impact factor.Abstract:
Objectives
Publication bias may affect the validity of evidence based medical decisions. The aim of this study is to assess whether research outcomes affect the dissemination of clinical trial findings, in terms of rate, time to publication, and impact factor of journal publications.
Methods and Findings
All drug-evaluating clinical trials submitted to and approved by a general hospital ethics committee between 1997 and 2004 were prospectively followed to analyze their fate and publication. Published articles were identified by searching Pubmed and other electronic databases. Clinical study final reports submitted to the ethics committee, final reports synopses available online and meeting abstracts were also considered as sources of study results. Study outcomes were classified as positive (when statistical significance favoring experimental drug was achieved), negative (when no statistical significance was achieved or it favored control drug) and descriptive (for non-controlled studies). Time to publication was defined as time from study closure to publication. A survival analysis was performed using a Cox regression model to analyze time to publication. Journal impact factors of identified publications were recorded. Publication rate was 48·4% (380/785). Study results were identified for 68·9% of all completed clinical trials (541/785). Publication rate was 84·9% (180/212) for studies with results classified as positive and 68·9% (128/186) for studies with results classified as negative (p<0·001). Median time to publication was 2·09 years (IC95 1·61–2·56) for studies with results classified as positive and 3·21 years (IC95 2·69–3·70) for studies with results classified as negative (hazard ratio 1·99 (IC95 1·55–2·55). No differences were found in publication impact factor between positive (median 6·308, interquartile range: 3·141–28·409) and negative result studies (median 8·266, interquartile range: 4·135–17·157).
Conclusions
Clinical trials with positive outcomes have significantly higher rates and shorter times to publication than those with negative results. However, no differences have been found in terms of impact factor.read more
Citations
More filters
Posted ContentDOI
Selective enhancement of low-gamma activity by tACS improves phonemic processing and reading accuracy in dyslexia
Silvia Marchesotti,Johanna Nicolle,Isabelle Merlet,Luc H. Arnal,John P. Donoghue,Anne-Lise Giraud +5 more
TL;DR: A causal role of neural oscillations in phonological processing is formally established, and solid neurophysiological grounds for a potential correction of low-gamma anomalies, and for alleviating of the phonological deficit in dyslexia are offered.
Journal ArticleDOI
Chronic Hepatitis B stigma in Ghana: a qualitative study with patients and providers.
Charles Ampong Adjei,Charles Ampong Adjei,Sarah E. Stutterheim,Florence Naab,Robert A. C. Ruiter +4 more
TL;DR: Given the prevalence of incorrect knowledge, as reflected in the beliefs about Hepatitis B, public awareness campaigns that emphasise hepatitis B transmission routes are recommended, and the development and implementation of a continuing professional development programme on hepatitis B is recommended.
Journal ArticleDOI
The miR-181a-SFRP4 axis regulates Wnt activation to drive stemness and platinum resistance in ovarian cancer.
Anil Belur Nagaraj,Matthew Knarr,Sreeja C. Sekhar,R. Shae Connor,Peronne Joseph,Olga Kovalenko,Alexis Fleming,Arshia Surti,Elmar Nurmemmedov,Luca Beltrame,Sergio Marchini,Michael Kahn,Analisa DiFeo +12 more
TL;DR: Using an miRNA sensor-based approach, this article identified miR-181a as a novel driver of Wnt/β-catenin signaling, which was associated with increased stem-cell frequency and platinum resistance.
Posted ContentDOI
Identification of common molecular biomarker signatures in blood and brain of Alzheimer’s disease
Md. Rezanur Rahman,Tania Islam,Md. Shahjaman,Julian M.W. Quinn,R. M. Damian Holsinger,Mohammad Ali Moni,Mohammad Ali Moni +6 more
TL;DR: In this paper, the authors identified new putative links between pathological processes in brain and transcripts in blood cells in AD subjects that may enable the use of blood to diagnose and monitor AD onset and progression.
Journal ArticleDOI
Age-related modulations of alpha and gamma brain activities underlying anticipation and distraction.
Hesham A. ElShafei,Hesham A. ElShafei,Lesly Fornoni,Rémy Masson,Olivier Bertrand,Aurélie Bidet-Caulet +5 more
TL;DR: Results show that the ageing-related increased distractibility is of TD origin, and the impact of ageing upon the oscillatory activities involved in TD and BU attention.
References
More filters
Journal ArticleDOI
Pharmacological interventions for somatoform disorders in adults.
Maria Kleinstäuber,Michael Witthöft,Andrés Steffanowski,Harm W.J. van Marwijk,Wolfgang Hiller,Michael J. Lambert +5 more
TL;DR: A systematic review and meta-analysis of placebo-controlled studies examined the efficacy and tolerability of different types of antidepressants, the combination of an antidepressant and an antipsychotic, antipsychotics alone, or natural products in adults with somatoform disorders in adults to improve optimal treatment decisions.
Journal ArticleDOI
Improving the quality of reporting of randomized controlled trials. The CONSORT statement.
Colin B. Begg,Mildred K. Cho,Susan Eastwood,Richard Horton,David Moher,Ingram Olkin,Roy M. Pitkin,Drummond Rennie,Kenneth F. Schulz,David L. Simel,Donna F. Stroup +10 more
TL;DR: For RCTs to ultimately benefit patients, the published report should be of the highest possible standard and should provide the reader with the ability to make informed judgments regarding the internal and external validity of the trial.
Journal ArticleDOI
Publication bias in clinical research
TL;DR: The presence of publication bias in a cohort of clinical research studies is confirmed and it is suggested that conclusions based only on a review of published data should be interpreted cautiously, especially for observational studies.
Journal ArticleDOI
Improving the quality of reporting of randomized controlled trials. The CONSORT statement
Colin B. Begg,Mildred K. Cho,Susan Eastwood,Richard Horton,David Moher,Ingram Olkin,Roy M. Pitkin,Drummond Rennie,Kenneth F. Schulz,David L. Simel,Donna F. Stroup +10 more
TL;DR: For RCTs to ultimately benefit patients, the published report should be of the highest possible standard and accurate and complete reporting is needed.
Journal ArticleDOI
Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles.
TL;DR: The reporting of trial outcomes is not only frequently incomplete but also biased and inconsistent with protocols and Published articles, as well as reviews that incorporate them, may therefore be unreliable and overestimate the benefits of an intervention.